These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25653529)

  • 41. Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity.
    Gao K; Wang Z; Chen J; Kemp DE; Chan PK; Conroy CM; Serrano MB; Ganocy SJ; Calabrese JR
    J Affect Disord; 2013 Jun; 148(2-3):256-64. PubMed ID: 23273550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between depression/anxiety symptom severity and quality of life in patients with major depressive disorder or bipolar disorder.
    Gao K; Su M; Sweet J; Calabrese JR
    J Affect Disord; 2019 Feb; 244():9-15. PubMed ID: 30292023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS.
    Carmody TJ; Rush AJ; Bernstein IH; Brannan S; Husain MM; Trivedi MH
    J Affect Disord; 2006 Oct; 95(1-3):115-8. PubMed ID: 16707162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.
    Liu J; Xiang YT; Lei H; Wang Q; Wang G; Ungvari GS; Morris DW; Zhu XZ; Lai KY; Zhong BL; Wong SY; Zhang L; Zhang Q; Zou YC; Xiao L; Zhao Q; Li Y; Wu J; Zhang GF; Chiu HF
    J Affect Disord; 2014 Jan; 152-154():530-3. PubMed ID: 24144585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depression Symptomatology and Anterior Cruciate Ligament Injury: Incidence and Effect on Functional Outcome--A Prospective Cohort Study.
    Garcia GH; Wu HH; Park MJ; Tjoumakaris FP; Tucker BS; Kelly JD; Sennett BJ
    Am J Sports Med; 2016 Mar; 44(3):572-9. PubMed ID: 26628516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of painful physical symptoms on depression outcomes in elderly Asian patients.
    Novick D; Montgomery W; Bertsch J; Peng X; Brugnoli R; Haro JM
    Int Psychogeriatr; 2014 Nov; ():1-8. PubMed ID: 25366979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
    Novick D; Montgomery W; Kadziola Z; Moneta V; Peng X; Brugnoli R; Haro JM
    Patient Prefer Adherence; 2013; 7():463-70. PubMed ID: 23818764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of pain and remission in the functioning of patients with depression in Mainland China, Taiwan, and Hong Kong.
    Novick D; Shi Q; Yue L; Moneta MV; Siddi S; Haro JM
    Asia Pac Psychiatry; 2018 Jun; 10(2):e12295. PubMed ID: 28960863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study.
    Schaakxs R; Comijs HC; Lamers F; Kok RM; Beekman ATF; Penninx BWJH
    Lancet Psychiatry; 2018 Jul; 5(7):581-590. PubMed ID: 29887519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms.
    Sugawara N; Yasui-Furukori N; Tsuji T; Hayashi S; Ajisawa Y; Ochiai T; Imagawa H; Shimoda K
    Neuropsychiatr Dis Treat; 2020; 16():3063-3070. PubMed ID: 33335397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
    Hong J; Novick D; Montgomery W; Aguado J; Dueñas H; Peng X; Haro JM
    Clin Pract Epidemiol Ment Health; 2015; 11():130-9. PubMed ID: 25870649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.
    Weiss B; Erritzoe D; Giribaldi B; Nutt DJ; Carhart-Harris RL
    J Psychopharmacol; 2023 Jul; 37(7):717-732. PubMed ID: 37122239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group-Based Symptom Trajectory of Intramuscular Administration of Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Post-Hoc Analysis.
    Wang X; Zhu X; Ji X; Yang J; Zhou J
    Neuropsychiatr Dis Treat; 2023; 19():1043-1053. PubMed ID: 37153351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups.
    Dell'osso B; Camuri G; Dobrea C; Buoli M; Serati M; Altamura AC
    Clin Pract Epidemiol Ment Health; 2012; 8():120-5. PubMed ID: 23166563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder: A Three-Month Observational Study.
    Lee MS; Yum SY; Hong JP; Yoon SC; Noh JS; Lee KH; Kim JK; Lee SY; Singh P; Treuer T; Reed V; Raskin J
    Psychiatry Investig; 2009 Dec; 6(4):255-63. PubMed ID: 20140123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Paper and Smartphone Versions of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) and the Patient Health Questionnaire-9 (PHQ-9) in Depressed Patients in China.
    Zhen L; Wang G; Xu G; Xiao L; Feng L; Chen X; Liu M; Zhu X
    Neuropsychiatr Dis Treat; 2020; 16():993-1001. PubMed ID: 32368061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.